Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

57.76
+0.12000.21%
Post-market: 57.920.1577+0.27%17:47 EST
Volume:671.45K
Turnover:38.94M
Market Cap:2.68B
PE:15.82
High:59.33
Open:57.70
Low:57.44
Close:57.64
52wk High:87.32
52wk Low:47.32
Shares:46.47M
Float Shares:46.47M
Volume Ratio:0.46
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.65
EPS(LYR):3.31
ROE:19.30%
ROA:6.45%
PB:2.94
PE(LYR):17.45

Loading ...

Haemonetics (HAE) Balances Softer Interventional Sales With Buybacks – What Story Does Guidance Tell?

Simply Wall St.
·
Feb 13

Haemonetics Corporation Releases 2024-2025 Corporate Responsibility Report

Reuters
·
Feb 13

BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting

GlobeNewswire
·
Feb 11

Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting

GlobeNewswire
·
Feb 10

Haemonetics Earnings Call: Strong Core, IVT Drag

TIPRANKS
·
Feb 08

These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings

Benzinga
·
Feb 07

Stock Track | Haemonetics Plummets 5.04% Intraday Following Series of Analyst Price Target Cuts

Stock Track
·
Feb 06

Haemonetics price target lowered to $81 from $99 at Baird

TIPRANKS
·
Feb 06

Haemonetics Is Maintained at Outperform by Barrington Research

Dow Jones
·
Feb 06

Haemonetics price target lowered to $75 from $88 at Citi

TIPRANKS
·
Feb 06

Haemonetics Price Target Maintained With a $88.00/Share by BTIG

Dow Jones
·
Feb 06

Orchestra Biomed Unveils Vision for Growth With Updates on Pivotal Cardiovascular Trials and Strategic Partnerships

Reuters
·
Feb 06

Earnings Flash (HAE) Haemonetics Posts Fiscal Q3 Adjusted EPS $1.31, vs. FactSet Est of $1.22

MT Newswires Live
·
Feb 05

Haemonetics Outlook FY Organic Growth 0-2%

THOMSON REUTERS
·
Feb 05

Haemonetics Q3 Adjusted EPS USD 1.31 VS. Ibes Estimate USD 1.25

THOMSON REUTERS
·
Feb 05

GUIDANCE:(HAE) Haemonetics Expects Fiscal 2026 Adjusted EPS Range $4.90 - $5, vs. FactSet Est of $4.70

MT Newswires Live
·
Feb 05

Haemonetics Q3 Adj. EPS $1.31 Beats $1.25 Estimate, Sales $338.967M Beat $331.616M Estimate

Benzinga
·
Feb 05

Haemonetics posts Q3 adjusted earnings per share of USD 1.31, up 10%

Reuters
·
Feb 05

Haemonetics meldet für das dritte Quartal einen Umsatz von 56,6 Mio. USD, ein Rückgang um 19,6 Prozent

Reuters
·
Feb 05

Haemonetics meldet Free Cash Flow im dritten Quartal 2026 von 165,42 Mio. USD mit Anstieg um 233 Prozent

Reuters
·
Feb 05